Terms: = Gastric cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Clinical Outcome
1 results:
1. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract] [Full Text] [Related]
